| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/11/2003 | WO2003040385A3 Membrane protein interaction assays |
| 12/11/2003 | WO2003038121A3 Method for the detection of cytosine methylation in immobilised dna samples |
| 12/11/2003 | WO2003038120A3 Method for analysis of genomic methylation models |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods |
| 12/11/2003 | WO2003033663A8 Rankl mimics and uses thereof |
| 12/11/2003 | WO2003030622A3 Detection and characterization of pyschoactives using analysis of network level physiological responses in a neuronal sample |
| 12/11/2003 | WO2003029825A3 Method for predicting the sensitivity to chemotherapy |
| 12/11/2003 | WO2003029486A3 Single nucleotide polymorphisms predicting cardiovascular disease |
| 12/11/2003 | WO2003029481A3 Detection of dna hybridization on surfaces |
| 12/11/2003 | WO2003029422A3 Noonan syndrome gene |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003029292A3 Gene regulatory peptides |
| 12/11/2003 | WO2003027326A3 Nucleic acid sequencing by raman monitoring of molecular deconstruction |
| 12/11/2003 | WO2003027259A3 Assays for dna methylation changes |
| 12/11/2003 | WO2003025225A3 Pthr1 gene polymorphisms |
| 12/11/2003 | WO2003025220A3 Fusion proteins useful for detecting analytes |
| 12/11/2003 | WO2003025218A3 Methods and yeast strains for screening antifungal agents |
| 12/11/2003 | WO2003025132A3 Dna polymerases and mutants thereof |
| 12/11/2003 | WO2003020984A3 Terminal-phosphate-labeled nucleotides and methods of use |
| 12/11/2003 | WO2003020980A3 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 12/11/2003 | WO2003020902A3 Methods for blocking nonspecific hybridizations of nucleic acid sequences |
| 12/11/2003 | WO2003020877A3 Staining and sorting genomes and chromosomes using sequence-specific polyamides |
| 12/11/2003 | WO2003019147A3 Enzyme-amplified redox microarray detection process |
| 12/11/2003 | WO2003016484A3 Gleason grade 4/5 prostate cancer genes |
| 12/11/2003 | WO2003014143A3 Haplotype map of the human genome and uses therefor |
| 12/11/2003 | WO2003012451A3 Methods for detecting of intermoleculair interactions using protein arrays |
| 12/11/2003 | WO2003012390A3 Methods and devices for detecting hydrocarbons and petroleum products |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003008552A3 Mll translocations specify a distinct gene expression profile, distinguishing a unique leukemia |
| 12/11/2003 | WO2003002750A3 High throughput assay system |
| 12/11/2003 | WO2003002748A3 Detection of microbiological contaminants in samples of non-living material |
| 12/11/2003 | WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002101358A3 Multiplexed detection methods |
| 12/11/2003 | WO2002101086A3 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 12/11/2003 | WO2002099383A8 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 12/11/2003 | WO2002089567A3 Sca2 knockout animal and methods of use |
| 12/11/2003 | WO2002088387A3 Amplification process |
| 12/11/2003 | WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 12/11/2003 | WO2002086448B1 Detection of microsatellite instability and its use in diagnosis of tumors |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |
| 12/11/2003 | WO2002074989A3 Disease associated polymorphism in the ctla-4 locus |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002070731A3 Methods and primers for evaluating hiv-1 mutations |
| 12/11/2003 | WO2002070728A3 Quantitative assay for the simultaneous detection and speciation of bacterial infections |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002065136A3 Yeast screens for agents affecting protein folding |
| 12/11/2003 | WO2002064835A3 Methods for nucleic acid fingerprint analysis |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002061085A3 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
| 12/11/2003 | WO2002059560A3 A method and system for predicting the biological activity, including toxicology and toxicity, of substances |
| 12/11/2003 | WO2002059365A8 Method and apparatus for simultaneous quantification of different radionuclides on the surface of a biological microarray |
| 12/11/2003 | WO2002052040A3 Method for the simultaneous amplification of multiple sequences in a pcr reaction and marking thereof |
| 12/11/2003 | WO2002046448A3 Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2002044412A8 Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interactions |
| 12/11/2003 | WO2002043758A3 Uses of mammalian genes and related reagents |
| 12/11/2003 | WO2002036608A3 Haplotypes of the cyp1a2 gene |
| 12/11/2003 | WO2002004677A8 Methods for diagnosis and treatment of psychiatric disorders |
| 12/11/2003 | WO2002000939A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/11/2003 | US20030229911 Compositions and methods for wound healing |
| 12/11/2003 | US20030229910 Preparing transgenic cattle which are resistant to bovine spongioform encephalopathy; homologous recombination; animal husbandry; veterinary medicine |
| 12/11/2003 | US20030229906 Preventing kidney cell dedifferentiation and viral nephropathy using peptide inhibitors; enzyme inhibitors; viricides; mimetics |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component |
| 12/11/2003 | US20030229219 Preparation of phosphorothioate oligomers |
| 12/11/2003 | US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229035 Method of restoring ciliated cell motility |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229005 Assays for measuring matrix metalloproteinase activities |
| 12/11/2003 | US20030228709 Arrays |
| 12/11/2003 | US20030228706 Petal-array support for use with microplates |
| 12/11/2003 | US20030228694 Transfection method and uses related thereto |
| 12/11/2003 | US20030228674 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/11/2003 | US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2003 | US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders |
| 12/11/2003 | US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 12/11/2003 | US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening |
| 12/11/2003 | US20030228657 Methods for enhancing the translation and expression of recombinant proteins |
| 12/11/2003 | US20030228650 As antifungal agents |
| 12/11/2003 | US20030228649 Polypeptides for identifying fungicidally active compounds |
| 12/11/2003 | US20030228648 Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities |
| 12/11/2003 | US20030228646 Fluorescence-based assays for determining the phosphorylating or the dephosphorylating activity of an enzyme acting on a substrate molecule |
| 12/11/2003 | US20030228645 Methods for the identification of inhibitors of chitin synthase 2 as antibiotics |
| 12/11/2003 | US20030228643 Use of ylqF, yqeG, yybQ, yerL, and ysxC, essential bacterial genes and polypeptides |
| 12/11/2003 | US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer |
| 12/11/2003 | US20030228638 Isolating endothelial cells from whole blood and detecting human leukocte antigen specific antibody complexes for diagnosing organ rejection, blood, wound healing and vascular diseases |
| 12/11/2003 | US20030228633 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function |
| 12/11/2003 | US20030228631 Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
| 12/11/2003 | US20030228626 Product |
| 12/11/2003 | US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 12/11/2003 | US20030228623 For rapid production of diverse populations of selectable compounds as well as ready selection from such populations of small molecules attached to display peptides that bind target molecules or have desired activities (e.g. antibiotics); drugs |